Analysis of Endothelial Protein C Receptor Gene and Metabolic Profile in Prader‐Willi Syndrome and Obese Subjects
- 1 September 2012
- Vol. 20 (9), 1866-1870
- https://doi.org/10.1038/oby.2011.349
Abstract
The endothelial protein C receptor (EPCR) has a critical role in the regulation of anticoagulant and anti-inflammatory functions of activated protein C (APC). Abnormalities in EPCR might be associated with an increased risk of thrombosis. In this respect, a 23 bp insertion in the exon 3 of the EPCR gene predicts a truncated protein which cannot bind APC. High levels of C-reactive protein (CRP), a strong predictor of cardiovascular events, are found both in the obese and in subjects with Prader-Willi syndrome (PWS). Several cardiovascular risk factors are already present in prepubertal PWS children, but it is uncertain which mechanism contributes to the increased risk of cardiovascular disease in PWS. We analyzed the distribution of 23 bp insertion in the EPCR gene in 81 overweight and obese PWS subjects, 52 adults and 29 children, and in 58 overweight and obese children and adolescents (controls). We found that 1/58 (1.7%) of the controls was heterozygous for the 23 bp insertion, while this mutation was never found in PWS subjects. Furthermore, we evaluated CRP levels, glucose, insulin, and lipid profile, and we found higher CRP values in PWS adults with respect to children with PWS and controls, and a better insulin sensitivity in all PWS subjects than in the controls. This study suggests that in PWS subjects there is no predisposition to develop thrombotic events in association with EPCR gene alteration and demonstrates substantial differences regarding metabolic and inflammatory profile between PWS and non-PWS obese children, with further impairment in adults with PWSKeywords
This publication has 35 references indexed in Scilit:
- Review of 64 cases of death in children with Prader–Willi syndrome (PWS)American Journal of Medical Genetics Part A, 2008
- The Italian National Survey for Prader–Willi syndrome: An epidemiologic studyAmerican Journal of Medical Genetics Part A, 2008
- Inflammatory Markers in Adults with Prader-Willi Syndrome before and during 12 Months Growth Hormone TreatmentHormone Research in Paediatrics, 2006
- Mortality in Prader-Willi SyndromeAmerican Journal on Mental Retardation, 2006
- C-reactive protein decreases expression of thrombomodulin and endothelial protein C receptor in human endothelial cellsSurgery, 2005
- Insulin resistance and obesity‐related factors in Prader–Willi syndrome: Comparison with obese subjectsClinical Genetics, 2004
- Epcr 23 bp insertion in a patient with severe progressive arterial disease: a dominant loss of function mutant in conditions of increased apc request?British Journal of Haematology, 2002
- Visceral Adipose Tissue and Metabolic Complications of Obesity Are Reduced in Prader-Willi Syndrome Female Adults: Evidence for Novel Influences on Body Fat DistributionJournal of Clinical Endocrinology & Metabolism, 2001
- Premature coronary artery disease and the Prader-Willi syndromePublished by Oxford University Press (OUP) ,1990
- Premature coronary artery atherosolerosis in a patient with Prader‐Willi syndromeAmerican Journal of Medical Genetics, 1987